Himadri Speciality Chemical Announces 38th AGM on June 11, 2026, Proposes ₹0.80 Dividend
Himadri Speciality Chemical Limited will hold its 38th AGM on June 11, 2026, via VC/OAVM. The company proposes a final dividend of ₹0.80 per equity share for FY26. Re-appointments of directors and ratification of cost auditor remuneration are also on the agenda. The record date for dividend is May 22, 2026.
The announcement concerns the AGM, dividend proposal, and director re-appointments, which are standard corporate governance events. The dividend amount is a material fact for shareholders.
The announcement is a routine corporate communication regarding the Annual General Meeting and dividend declaration, with no significant positive or negative financial or business developments mentioned.
Himadri Speciality Chemical Limited (HSCL) has announced its 38th Annual General Meeting (AGM) will be held on Thursday, June 11, 2026, at 11:00 a.m. IST through Video Conferencing (VC) and Other Audio-Visual Means (OAVM). The company will present the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026.
A final dividend of ₹0.80 per equity share of face value ₹1 each for the financial year ended March 31, 2026, has been proposed, subject to shareholder approval at the AGM. The meeting will also address the re-appointment of directors, including Mr. Anurag Choudhary who retires by rotation, and the re-appointment of Mr. Girish Paman Vanvari and Mr. Gopal Ajay Malpani as Independent Directors for their second terms.
The remuneration of the Cost Auditor for the financial year ending March 31, 2027, will also be ratified. The Integrated Annual Report for the financial year 2025-26, along with the Notice of the 38th AGM, has been dispatched via email to members and will be available on the company's website and stock exchange websites. The record date for determining eligibility for the proposed dividend is May 22, 2026.
What to do with a filing like this
Himadri Speciality Chemical Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Himadri Speciality Chemical Limited. Read the original for the full detail.